Jan 5, 2026 7:05 am EST NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Dec 30, 2025 7:05 am EST NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
Dec 15, 2025 7:05 am EST NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
Dec 8, 2025 8:05 am EST NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
Oct 30, 2025 12:51 pm EDT NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
